Targeteddd Hemostasis
Tranexamic Acid acts as a competitive inhibitor of plasminogen activation. By blocking the binding of plasminogen to fibrin, it stabilizes clots and significantly reduces menstrual blood loss by up to 60%. (Lukas et al., 2007)
Loading...

Mefenamic Acid 250mg+Tranexamic Acid 500 mg
A specialized dual-action formula designed for the effective management of heavy menstrual bleeding and associated pelvic pain. NEXSTAT-M combines a potent antifibrinolytic agent to control excessive blood loss with a targeted NSAID to reduce uterine contractions and discomfort.
A specialized dual-action formula designed for the effective management of heavy menstrual bleeding and associated pelvic pain. NEXSTAT-M combines a potent antifibrinolytic agent to control excessive blood loss with a targeted NSAID to reduce uterine contractions and discomfort.
Tranexamic Acid acts as a competitive inhibitor of plasminogen activation. By blocking the binding of plasminogen to fibrin, it stabilizes clots and significantly reduces menstrual blood loss by up to 60%. (Lukas et al., 2007)
Mefenamic Acid inhibits the enzyme cyclooxygenase (COX), reducing the levels of prostaglandins in the endometrium. This action decreases both uterine inflammation and excessive bleeding. (Markham and Bryson, 1995)
The analgesic properties of Mefenamic Acid provide fast relief from spasmodic dysmenorrhea (cramps) by relaxing the smooth muscles of the uterus. (Toussaint ...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.